Nasic Pur (Xylometazoline Hydrochloride, Dexpanthenol)

Xylometazoline is an α‑adrenergic agonist. When applied to the nasal mucosa it stimulates α1‑receptors on vascular smooth muscle, causing vasoconstriction. This reduces swelling and excess fluid in the nasal passages, quickly opening the airway. Dexpanthenol simultaneously supports mucosal healing.

The exact dosing regimen for Nasic Pur is determined by the prescribing healthcare professional. Typically, a few sprays per nostril are used, but the prescriber will set the frequency and duration based on the patient’s age, condition severity and response to therapy.

Safety data for xylometazoline and dexpanthenol in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using Nasic Pur.

To place an order, submit an enquiry on the Nasic Pur product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Nasic Pur combines xylometazoline with dexpanthenol, offering both rapid decongestion and mucosal moisturisation. Compared with oxymetazoline‑only products, it may cause slightly less dryness because dexpanthenol helps maintain epithelial health, though both agents share similar efficacy and risk of rebound congestion if used beyond recommended duration.

Store Nasic Pur at room temperature, below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from moisture, direct sunlight and extreme heat. Do not freeze the product, and keep it out of reach of children.

Nasic Pur is administered as a nasal spray. Gently blow the nose to clear excess mucus, tilt the head slightly forward, insert the nozzle into one nostril, and press the pump to deliver the recommended number of sprays. Repeat in the other nostril if instructed, and avoid blowing the nose immediately after use.

Serious risks include rebound nasal congestion (rhinitis medicamentosa) after prolonged use, significant elevation of blood pressure or heart rate, and rare severe allergic reactions such as anaphylaxis. Patients experiencing persistent nasal blockage, hypertension, chest pain, or signs of an allergic response should discontinue use and seek medical attention promptly.

Nasic Pur should be avoided in children younger than 6 years, individuals with severe hypertension, those taking monoamine oxidase inhibitors, or patients with known hypersensitivity to xylometazoline, dexpanthenol or any excipients. Persons with certain cardiovascular disorders should consult a physician before use.